EUVIMEDEUVIMED entdecken
Open Access

Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma

Jing Yang, Lin-Yin Fan, Kai-Yuan Shi

International Journal of Medical Sciences · 2024

DOI: 10.7150/ijms.94812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Jing Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

PtdIns (3,4,5) P3-dependent Rac exchanger 1 (PREX1), also known as PREX1, a member of the Rac guanine nucleotide exchange factors (Rac-GEF) family. Studies have suggested that PREX1 plays a role in mediating oncogenic pathway activation and controlling various biological mechanisms in different types of cancer, including liver hepatocellular carcinoma (LIHC). However, the function of PREX1 in the pathogenesis of LIHC and its potential role on immunological regulation is not clearly elucidated.

Methods

The expression level and the clinical role of PREX1 in LIHC was analyzed based on database from the Cancer Genome Atlas (TCGA), TNM plotter and University of Alabama Cancer Database (UALCAN). We investigated the relationship between PREX1 and immunity in LIHC by TISIDB, CIBERSORT and single cell analysis. Immunotherapy responses were assessed by the immunophenoscores (IPS). Moreover, biological functional assays were performed to further investigate the roles of PREX1 in liver cancer cell lines.

Results

Higher expression of PREX1 in LIHC tissues than in normal liver tissues was found based on public datasets. Further analysis revealed that PREX1 was associated with worse clinical characteristics and dismal prognosis. Pathway enrichment analysis indicated that PREX1 participated in immune-related pathways. Through CIBERSORT and single cell analysis, we found a remarkable correlation between the expression of PREX1 and various immune cells, especially macrophages. In addition, high PREX1 expression was found to be associated with a stronger response to immunotherapy. Furthermore, in vitro assays indicated that depletion of PREX1 can suppress invasion and proliferation of LIHC cells.

Conclusion

Elevated expression of PREX1 indicates poor prognosis, influences immune modulation and predicts sensitivity of immunosuppression therapy in LIHC. Our results suggested that PREX1 may be a prognostic biomarker and therapeutic target, offering new treatment options for LIHC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticSingle-Cell AnalysisHumansPrognosisGene Expression ProfilingCell Line, TumorGuanine Nucleotide Exchange FactorsMaleTranscriptomePhospholipid Transfer ProteinsTumor MicroenvironmentFemale

Stichwörter der Autor:innen

Immune infiltrationLiver hepatocellular carcinomaPREX1PrognosisSingle cell analysis

Substanzen

Biomarkers, TumorPREX1 protein, humanGuanine Nucleotide Exchange FactorsPhospholipid Transfer Proteins

Autor:innen und Institutionen

  • Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
  • Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.

Zitieren

APA

Yang, J., Fan, L. Y., & Shi, K. Y. (2024). Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.94812

Vancouver

Yang J, Fan LY, Shi KY. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.94812

BibTeX
@article{Yang2024,
  author = {Yang, Jing and Fan, Lin-Yin and Shi, Kai-Yuan},
  title = {Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma},
  journal = {International Journal of Medical Sciences},
  year = {2024},
  doi = {10.7150/ijms.94812}
}
Kostenlos starten →